News

Uncertainty around pharma tariffs on and pricing policies under the Trump has much of the sector guessing what will happen ...
Analysts are still crunching the numbers on the impact of President Donald Trump's executive order from Monday on drug pricing. HSBC analyst Rajesh Kumar says a 20% price cut in government channels ...
Shares of U.S. drugmakers rebounded on Monday after an initial selloff as analysts said that President Donald Trump's ...
Merck & Co.‘s planned debut this fall of an injectable form of its breakthrough cancer treatment Keytruda will simplify care, ...
Pharmacy stocks, including Eli Lilly (LLY), Johnson & Johnson (JNJ), and Merck (MRK), are moving to the downside after US President Trump said he will cut drug prices by over 50%. To watch more ...
Announcement pressures pharma stocks on worries profits will be hit if they have to cut prices in US. Read more at ...